FDA Inspection 1230687 — Lantheus Medical Imaging, Inc.
The FDA completed an inspection of Lantheus Medical Imaging, Inc. on December 21, 2023 in North Billerica, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 21, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Billerica, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)